FactorPad
Build a Better Process

Stock Risk Measures for Iovance Biotherapeutics Inc

A quantitative factor review, as of September 30, 2020.
  1. Company Info - Description, identity and sector data.
  2. Share Data - Stock earnings and key dates.
  3. Market Risk - Beta, size, liquidity and momentum measures.
  4. Financial Risk - Earnings and dividends.
by Paul Alan Davis, CFA
Updated: October 01, 2020
See how we arrive at an overall risk score of 51 for IOVA below.

/ factorpad.com / stocks / f29bqp.html


An ad-free and cookie-free webpage by FactorPad


IOVA Risk Report

Overview

Our quantitative data points are meant to provide a high-level understanding of factors in equity risk models for Iovance Biotherapeutics Inc. Portfolio managers use these models to forecast risk, optimize portfolios and review performance.

We show how IOVA stock compares to 2,000+ US-based stocks, and to peers in the Health Technology sector and Biotechnology industry.

Please do not consider this data as investment advice. Data is downloaded from sources we deem reliable, but errors may occur.

Company Info

Business Description

Company logo Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Identity

Sector and Industry

Share Data

Shares and Float

Earnings and Dividends

Market Risk Measures

Many of the following risk metrics are standardized and transformed into quantitative factors in institutional-level risk models.

Rankings below represent percentiles from 1 to 100, with 1 being the lowest rating of risk.

Systematic Risk

Stocks with higher beta exhibit higher sensitivity to the ups and downs in the market. (↑↑)

Company Size

Stocks with higher market capitalization often have lower risk. (↑↓)

Trading Liquidity

Higher average daily dollar volume over the past 30 days implies lower liquidity risk. (↑↓)

Price Momentum

Higher price momentum stocks, aka recent winners, equate to lower risk for many investors. (↑↓)

Financial Risk Measures

Style risk factors often include measures of profitability and payout levels.

Earnings Yield

Companies with higher earnings generally provide lower risk. (↑↓)

Dividend Yield

Companies with higher dividend yields, if sustaintable, are perceived to have lower risk. (↑↓)

/ factorpad.com / stocks / f29bqp.html


IOVA stock risk
IOVANCE BIOTHERAPEUTICS INC stock beta
IOVA risk report
IOVA f29bqp
IOVA risk analysis
IOVA volatility
IOVANCE BIOTHERAPEUTICS INC credit risk
IOVA liquidity risk
IOVA leverage
IOVA valuation
IOVA systematic risk
IOVA specific risk
IOVANCE BIOTHERAPEUTICS INC volatility
IOVA analysis
IOVA financial ratio

This is a new resource, spread the word, tell a friend